ResearcherNorthwell HealthNo recent work listed

Dimitrios Giannis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9246-976X; OpenAlex author ID A5063318762. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper

Papers 2

Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians. Co-author DOI 10.3390/cancers13051071 ↗
Initial experience with neoadjuvant FOLFIRINOX as first line therapy for locally advanced pancreatic cancer. Co-author PMID 33277879 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dimitrios Moris · 2 shared papers, 2020–2021 · strength 0.36
- Paper Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians. DOI 10.3390/cancers13051071 ↗
- Paper Initial experience with neoadjuvant FOLFIRINOX as first line therapy for locally advanced pancreatic cancer. PMID 33277879 ↗
Andrew S. Barbas · 1 shared paper, 2021 · strength 0.22
- Paper Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians. DOI 10.3390/cancers13051071 ↗
Athanasios S. Petrou · 1 shared paper, 2020 · strength 0.13
- Paper Initial experience with neoadjuvant FOLFIRINOX as first line therapy for locally advanced pancreatic cancer. PMID 33277879 ↗
Georgia Sofia Karachaliou · 1 shared paper, 2020 · strength 0.13
- Paper Initial experience with neoadjuvant FOLFIRINOX as first line therapy for locally advanced pancreatic cancer. PMID 33277879 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.